Alex's Lemonade Stand Foundation for Childhood Cancer

Acute myeloid leukemia (AML) is the second most common childhood leukemia but is reaching acute lymphoblastic leukemia (ALL) as the leading cause of childhood leukemic mortality, primarily because of ineffective prognostic schemas and the absence of targeted therapies. While there have been significant advancements in supportive care and targeted treatments, AML shows a worse long-term prognosis across all groups when compared to other acute leukemias.

The Aflac Cancer Center at Children's Healthcare of Atlanta (CHOA) is one of the largest oncology programs in the United States and is a member of the NCI designated Comprehensive Cancer Center- Winship Cancer Institute of Emory University. Approximately 350 new patients (100-125 brain tumors) and 100 relapsed patients are seen each year. In addition, CHOA serves as the statewide and southeastern referral center for phase I/II patients.